DuraVax Inc.
PrivateLast Round
Grant
May 1, 2024
Total Funding Raised
$274,991
Company Overview
DuraVax Inc. operates in Healthcare & Life Sciences and is based in Wilmington, North Carolina. Its latest recorded funding round was a Grant round in May 2024.
DuraVax Inc. is a biotechnology company that develops stabilized biological formulation technologies to eliminate cold-chain requirements for mRNA vaccines and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DuraVax Inc. Comparables
Compare DuraVax Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnsiliTech | 80% | |
| Stablepharma | 80% | |
| VitriVax, Inc. | 77% |
For institutional investors. Book with your work email.
DuraVax Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2024 | ||||
| Grant | Apr 4, 2024 |
For institutional investors. Book with your work email.
DuraVax Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NCInnovation | Grant |
| North Carolina Biotechnology Center | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2024
Received grant funding from NCInnovation.
- Apr 4, 2024
$275K grant from National Science Foundation and others.
For institutional investors. Book with your work email.
DuraVax Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DuraVax Inc.'s valuation, stock price, and market status.
Is DuraVax Inc. a public or private company?
DuraVax Inc. is a private company.
What is the current stock price of DuraVax Inc.?
DuraVax Inc. is a private company, so its shares have no public market price. Caplight tracks DuraVax Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DuraVax Inc. worth (valuation)?
Valuation information for DuraVax Inc. is not publicly available.
Can I buy DuraVax Inc. stock?
DuraVax Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DuraVax Inc.'s last funding round?
DuraVax Inc.'s most recent funding round was Grant on May 1, 2024.
Who are the main investors in DuraVax Inc.?
Key investors in DuraVax Inc. include NCInnovation, North Carolina Biotechnology Center, National Science Foundation.
Will DuraVax Inc. IPO soon?
No public IPO plans have been announced for DuraVax Inc..
How can I track DuraVax Inc. secondary market activity?
Caplight tracks bids, offers, and trades in DuraVax Inc.'s shares on secondary markets.